Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells

被引:0
作者
K. O'Connor
C. Gill
M. Tacke
F.-J. K. Rehmann
K. Strohfeldt
N. Sweeney
J. M. Fitzpatrick
R. W. G. Watson
机构
[1] Mater Misericordiae University Hospital,UCD School of Medicine and Medical Sciences
[2] University College Dublin,UCD School of Chemistry and Chemical Biology
[3] University College Dublin and Dublin Molecular Medicine Centre,Conway Institute
[4] Conway Institute,UCD School of Medicine and Medical Sciences
[5] University College Dublin,undefined
来源
Apoptosis | 2006年 / 11卷
关键词
Apoptosis; Cell cycle; Mitochondria; Prostate cancer; Titanocene;
D O I
暂无
中图分类号
学科分类号
摘要
Advanced prostate cancer is not curable by current treatment strategies indicating a significant need for new chemotherapeutic options. Highly substituted ansa-titanocene compounds have shown promising cytotoxic activity in a range of cancers. The objectives of this study are to examine the effects of these titanocene compounds on prostate cancer cells.
引用
收藏
页码:1205 / 1214
页数:9
相关论文
共 82 条
[1]  
Raghavan D(1997)Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer Eur J. Cancer 33 566-574
[2]  
Koczwara B(2003)Multidrug resistance in prostate cancer Onkologie 26 175-181
[3]  
Javle M(2001)The development of androgen-independent prostate cancer Nat. Rev. Cancer 1 34-45
[4]  
Van Brussel JP(1993)Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer Cancer 71 1098-1109
[5]  
Mickisch GH(2004)Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N. Engl. J. Med. 351 1502-1512
[6]  
Feldman BJ(1983)Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer J. Urol. 129 1001-1006
[7]  
Feldman D(1994)Complexes of metals other than platinum as antitumour agents Eur. J. Clin. Pharmacol. 47 1-16
[8]  
Yagoda A(1998)Anti-proliferative activity and mechanism of action of titanocene dichloride Br. J. Cancer 77 2088-2097
[9]  
Petrylak D(2000)Phase II clinical trial of titanocene dichloride in patients with metastatic breast cancer Onkologie 23 60-62
[10]  
Tannock IF(2004)Functionalized Cyclopentadienyl Titanium Organometallic Compounds as New Antitumor Drugs Organomet. 23 288-292